NewGenIvf Group (NASDAQ:NIVF) Announces Earnings Results

NewGenIvf Group (NASDAQ:NIVF) announced its earnings results on Wednesday, October 7th. The company reported ($111.54) earnings per share for the quarter, missing analysts’ consensus estimates of $581.76 by ($693.30), reports. The business had revenue of $0.96 million for the quarter, compared to analyst estimates of $20.10 million.

NewGenIvf Group Trading Down 14.1%

Shares of NASDAQ:NIVF opened at $0.98 on Friday. The firm’s 50 day moving average price is $18.44 and its 200-day moving average price is $409.90. NewGenIvf Group has a twelve month low of $0.96 and a twelve month high of $20,908.80.

Wall Street Analysts Forecast Growth

NIVF has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a research report on Friday, July 24th. Wall Street Zen cut NewGenIvf Group to a “strong sell” rating in a research report on Saturday, October 24th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company currently has an average rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIvf Group Limited (NASDAQ:NIVF) is a fertility-services company focused on assisted reproductive technology and related medical care. Through its NewGen IVF operations, the company provides services intended to help individuals and couples pursue pregnancy, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), fertility assessments and fertility-preservation procedures.

Its service offering also includes egg and sperm freezing, embryo-related services, genetic testing and donor-program support, subject to applicable medical and regulatory requirements.